LFTD Partners Inc.

LIFD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-80.0K $-181.7K $-1.2M $-5.3M $4.5M $-2.4M $-4.3M $-200.7K
Depreciation & Amortization — — — — — $34.8K $45.0K —
Depreciation — — — — — $2.6K $45.0K $42.6K
Amortization — — — — — $263.2K — —
Stock-Based Compensation $0 $0 $0 $5.1M $0 $449.9K $706.7K $405.9K
Net Cash from Operating Activities $-605 $-52.3K $-399.8K $-291.5K $-1.4M $-759.9K $-1.4M $-181.1K
Investing Activities
Capital Expenditures — — — — — — $-23.4K $-42.9K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $0 $25.0K $-160.4K $472.1K $3.9M $17.9K $-27.9K $-121.9K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — $20.0K $30.0K — — —
Net Cash from Financing Activities $0 $100 $0 $-20.0K $-2.3M $863.3K $1.2M $-298.4K
Net Change in Cash $-605 $-27.2K $-560.2K $160.6K $240.4K $121.2K $-213.8K —
Free Cash Flow — — — — — — $-1.4M $-138.3K
← Newer Page 2 of 2 Older →